Opendata, web and dolomites

CRISPR-GQ SIGNED

Identifying the Capabilities and Limitations of CRISPR in Targeting G-quadruplex Forming Sequences: From Target Recognition to Gene Expression Regulation

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 CRISPR-GQ project word cloud

Explore the words cloud of the CRISPR-GQ project. It provides you a very rough idea of what is the project "CRISPR-GQ" about.

regulatory    neurological    crispr    demonstrated    bloom    potentially    suggested    expression    guide    gq    pursue    wish    molecules    frontotemporal    canonical    frequency    quadruplex    specificity    small    prevent    complementary    molecule    palindromic    critical    sclerosis    amyotrophic    promoters    clustered    lateral    concentration    genes    structure    techniques    single    precision    strand    editing    dementia    variants    als    sequences    secondary    therapeutic    cas9    forefront    cas    ftd    gene    bulk    regulation    regulate    pqs    werner    genome    remove    genomic    assays    disorders    perform    form    absence    forming    effort    human    structures    sites    course    interspaced    vicinity    limitations    syndromes    elucidate    proteins    inhibit    promoter    inability    cells    translation    untranslated    transcription    dna    stabilizing    rna    certain    tyrosine    geared    oncogenes    enormous    myc    underway    constructs    hydroxylase    telomeric    region    regions    world   

Project "CRISPR-GQ" data sheet

The following table provides information about the project.

Coordinator
TECHNISCHE UNIVERSITEIT DELFT 

Organization address
address: STEVINWEG 1
city: DELFT
postcode: 2628 CN
website: www.tudelft.nl

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Project website https://sites.google.com/site/balcilab/research/mariecuriefellowshipreport
 Total cost 88˙799 €
 EC max contribution 88˙799 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2017
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2018
 Duration (year-month-day) from 2018-07-01   to  2019-06-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    TECHNISCHE UNIVERSITEIT DELFT NL (DELFT) coordinator 88˙799.00

Map

 Project objective

Clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR associated proteins (Cas) have recently been at the forefront of genomic research due to their enormous potential at editing the genome with great precision and specificity. A world-wide effort is currently underway to test Cas proteins and their variants for applications geared towards genome editing for human cells. How CRISPR-Cas systems perform in editing sequences that form non-canonical DNA or RNA secondary structures or are in the vicinity of such structures is the problem we wish to pursue during the course of proposed studies. One such structure is the G-quadruplex (GQ), which has been demonstrated to form throughout the human genome, with particular concentration in telomeric sites, promoters, and 3’ and 5’ untranslated regions of RNA. The higher frequency of potentially GQ forming sequences (PQS) at such regulatory sites has suggested a potential role for these structures in transcription or translation level gene expression regulation. GQ formation has been demonstrated to inhibit gene expression for a number of different genes, including certain critical oncogenes. Inability to remove these structures is directly associated with several syndromes, including Bloom and Werner syndromes, and neurological disorders such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Therefore, editing such sequences to prevent GQ formation also has therapeutic potential. We will design different single guide RNA constructs and target the GQ forming G-rich or the complementary C-rich strand to elucidate the capabilities and limitations of the CRISPR-Cas9 system in editing such structures using single molecule techniques and bulk assays. We will then investigate whether CRISPR-Cas9 can be used to regulate gene expression by targeting GQ structures in the promoter region of tyrosine hydroxylase and c-Myc genes in the presence and absence of GQ stabilizing small molecules.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CRISPR-GQ" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CRISPR-GQ" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

EngPTC2 (2019)

Exploring new technologies for the next generation pulse tube cryocooler below 2K

Read More  

pyrroQuin (2020)

Synthesis and Biological Evaluation of Pyrroquinoline Pseudo-Natural Products

Read More  

NSTree (2020)

Understanding substrate delivery for cell wall biosynthesis in plants

Read More